Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$0.99 - $4.15 $31,559 - $132,293
31,878 Added 98.69%
64,180 $70,000
Q1 2022

May 16, 2022

BUY
$3.5 - $9.11 $59,150 - $153,959
16,900 Added 109.73%
32,302 $129,000
Q4 2021

Feb 14, 2022

BUY
$8.32 - $12.45 $128,144 - $191,754
15,402 New
15,402 $131,000

Others Institutions Holding AYLA

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Ayala Pharmaceuticals, Inc.


  • Ticker AYLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,833,300
  • Description
  • Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinic...
More about AYLA
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.